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Abstracts / Urological Science 27 (2016) S1eS23S4Conclusion: Our results demonstrate that miR-30a-5p can sensitize BC
cells to cisplatin via suppressing ATG5 and BECN1 expression, therefore,
increasing miR-30a-5p level in BC represents a novel strategy to enhance
the efﬁcacy of cisplatin therapy during cancer treatment.
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Purpose: Increased urinary tract malignancy has been reported in end-
stage renal disease (ESRD). However, little is known about chronic kidney
disease (CKD). This study is designed to explore the association between
CKD and upper tract urothelial carcinoma (UTUC).
Materials and Methods: Using Taiwan's Longitudinal Health Insurance
Database, we studied CKD patients between January 2000 and December
2011. The non-CKD controls were selected at a ratio of 4:1 and frequency
matched by gender, age group and index date.We used Chi-square test and
t-test to analyze the sociodemographic information and comorbidities.
Cox regression analysis was used to calculate the hazard ratio (HR) and 95%
conﬁdence interval (CI).
Results: The selected cases included 45,321 CKD cases and 181,284 con-
trols. A signiﬁcantly higher incidence of UTUC was noted in the CKD group
(0.22% vs. 0.07%, p< 0.001). In univariate analysis, CKD, female gender, age,
hypertension, hematuria, repeated urinary tract infection, bladder cancer
and ESRD were all associated with UTUC. In multivariate analysis, only
CKD, female gender, age, hematuria, bladder cancer and ESRD were
signiﬁcantly associated. The HR for CKD was 1.63 (95% CI: 1.26e2.13). Fe-
males had a higher HR of 1.38 (95% CI: 1.11e1.71). After excluding those
patients who progressed to dialysis or kidney transplantation, the risk for
CKD was still high, with a HR of 1.72 (95% CI: 1.33e2.33).
Conclusion: CKD is a signiﬁcant factor associated with UTUC. We should
pay attention to the possibility of UTUC for CKD patients before they
progress to ESRD.
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Purpose: We propose a formula of calculate-based contact surface area
(CSA). We examined the correlation of contact surface area and renal
volume loss and the predictability for renal function after partial
nephrectomy.
Materials and Methods: We conducted a retrospective study in pa-
tients who underwent partial nephrectomy between January 2012 and
December 2014. Based on abdominopelvic CT and MRI, we calculated
the contact surface area with the formula “2* p *Radius*Depth”; while
resected and ischemic volume (RAIV) was determined by the equation”
[2w 2^+3w(r+d)+6rd]*w*p)⁄3”. We evaluated the correlation between
CSA, RAIV and perioperative parameters. And we comparatively
analyzed the ability of CSA and RAIV to predict the reduction in renal
function.
Results: There were 35, 26, and 45 patients receiving OPN, LPN, RPN
respectively. The mean±SD contact surface area was 30.7±26.1 cm2, and
and the mean±SD RAIV was 19.1±14.4 cm3. On Spearman correlation
analysis we found that CSA and RAIV were highly correlated (coefﬁ-
cient: 0.99, p < 0.001). In univariate analysis, BMI (p¼ 0.02), EBL(p¼ 0.001), RAIV (p < 0.001), and CSA (p < 0.001) signiﬁcantly affected
postoperative renal function. In ROC curve analysis, both CSA and RAIV
have good ability to predict more than 10% change of estimated
glomerular ﬁltration rate (AUC: 0.86 vs. 0.87). There is no signiﬁcant
difference in AUC between CSA and RAIV. The area difference in PCE10
was 0.002 (p¼ 0.51).
Conclusion: In our study, CSA and RAIV were correlated with several
perioperative outcomes and affected post-operative renal function. The
ability to predict post-operative renal function between CSA and RAIV was
nearly identical. Since CSA was simpler to use, and may possess less
interobserver variability in comparison with RAIV, we believe that CSA can
represent renal parenchymal loss.
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Purpose: Urothelial carcinomas (UCs) involve recurrent chromosome 9p
deletions. Methylthioadenosine phosphorylase (MTAP) on 9p21.3is a pro-
posed functional tumor suppressor gene. The role of MTAP in upper tract
UC (UTUC) is unknown. We aimed to investigate MTAP's association with
disease characteristics and oncologic outcomes in UTUC patients under-
going radical nephroureterectomy (RNU).
Materials and Methods: Using immunohistochemistry, we investigated
MTAP expression in 340 UTUC patients treated with RNU from1996e2004,
and correlated it with clinicopathologic characteristics and clinical out-
comes. Univariate and multivariate Cox regression analyses evaluated the
association of MTAP expression with disease-speciﬁc survival (DSS) and
metastasis-free survival (MeFS).
Results:MTAP was deﬁcient in 119 (35.0%) patients. MTAP deﬁciency was
signiﬁcantly associated with higher pathologic stage (p< 0.001), lymph
node metastasis (p< 0.001), high grade (p¼ 0.008), vascular invasion
(p¼ 0.001), perineural invasion (p¼ 0.001), and higher mitotic rate
(p¼ 0.016).Sixty (17.6%) patients died of UTUC and 70 (20.6%) developed
metastasis. MTAP-deﬁcient patients demonstrated signiﬁcantly worse DSS
(58.1% vs.89.3%; p< 0.0001) and MeFS (54.7% vs.87.9%; p< 0.0001) at ﬁve
years than those with intact expression. MTAP deﬁciency was indepen-
dently associated with cancer-speciﬁc mortality (hazard ratio [HR]:2.213,
p¼ 0.019; 95% conﬁdence interval [CI]:1.141e4.293) and metastasis
development (HR:2.867, p< 0.001; 95% CI:1.601e5.106).
Conclusion: MTAP deﬁciency is associated with aggressive cancer
phenotype and unfavorable oncologic outcomes, suggesting it may be a
new biomarker and provide additional prognostic information in UTUC
patients undergoing RNU.
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Purpose: We studied the gene copy number alteration of TPPP (Tubulin
Polymerization Promoting Protein) in bladder cancer using ﬂuorescence in
situ hybridization (FISH) based assay and correlated it's the result with
clinical parameters.
Materials and Methods: Samples and clinical data from patients with
bladder cancer and clinical data were collected. TPPP gene was evaluated
by FISH in 52 patients. The probe targeting the gene TPPPwere established
for FISH experiment. At least 300 non-overlapping cells in each case were
analyzed by two observers.
Results:We could see different genetic copy number alterations of TPPP in
studied sample. Further analysis with the clinical data, the TPPP gene
alteration was strongly correlated with tumor grade, in which the ampli-
ﬁcation of TPPP gene was signiﬁcantly correlated with high-grade tumor
(p< 0.001). Besides, the ampliﬁcation of TPPP gene was positively corre-
lated with tumor stage (p< 0.05).
Conclusion: The genetic alterations of TPPP gene were much higher in
high-stage and -grade bladder cancer. This result suggests that TPPP may
play a role in bladder cancer pathogenesis, and TPPP gene alteration may
serve as a biomarker for bladder cancer detection.
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Purpose: We evaluated the clinical outcomes of castration resistant
prostate cancer (CRPC) patients treated with Docetaxel in Taichung Vet-
erans General Hospital.
Materials and Methods: From Dec 2004 to Feb 2015, 208 patients with
castration resistant prostate cancer were treated with Docetaxel70-75mg/
m2, IV, every three to four weeks or 50mg/m2, every two weeks. The PSA
response, time to progression duration, overall survival and adverse events
wereanalyzed.
Results: The median age of the 208 patients was 69 years (range 44e86)
and the median PSA when started Docetaxel was 47 ng/ml (range
2.24e4761). The median treatment courses of the patients were 6 (range
1e44). PSA response was found in 105patients (50.5%). Twenty-eight pa-
tients (13.5%) had the phenomenon of PSA ﬂare up. The median progres-
sion free survival was 5 months (range 0e54) and the median overall
survival was 13 months (range 0e80). The most common subjective
adverse effects were neutropenia. About one-third patients (35%) had
grade3e4 neutropenia
Conclusion: Good PSA response and fair survival outcome were demon-
strated in CRPC patients treated with docetaxel. However, high risk of
neutropenia should be kept in mind.
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Purpose: Chloroquine (CQ) widely used to treat and prevent malaria, is
shown to be an important therapeutic compound to treat diseases such as# These authors contributed equally to this work.autoimmune disorders. Recently, CQ is also recognized as a potent adju-
vant agent when combined with other chemotherapeutic drugs to treat
cancers. However, the effects of a single treatment of CQ on bladder cancer
(BC) have not been investigated. In the present study, we aimed to examine
the cell death mechanism induced by CQ in BC cells.
Materials and Methods: The effect of CQ on the growth and viability of BC
cells (5637 and T24) in vitro was examined by cologenic formation assay
and WST-1 reagent, respectively. The morphology and numbers of lyso-
somes in live cells with or without CQ treatment was tracked using a
ﬂuorescent dye, LysoTracker. The induction of lysosomal membrane
permeability (LMP) was detected by acridine orange translocation, and
further investigated by the immunoﬂuorescent detection of cathepsin B
and D (CatB and CatD) release. The expression level of bid, caspase-3, and
cytosolic cytochrome c in CQ-treated cells was detected by Western blot.
Lysosomal protease inhibitors, pepstatin A and E64d were used to atten-
uate CQ-induced LMP.
Results: CQ exhibited cytotoxicity toward human bladder cancer cell lines.
Time-lapse monitoring of lysosomes labeled with LysoTracker showed
diminishing of ﬂuorescent in CQ-treated cells, suggesting that CQ targets
lysosomal functions. This was further supported by dose-dependent AO
translocation detected with increased concentration of CQ, and the
releasing of CatB and CatD into cytosol. The increased level of cleavage bid
and cytosolic cytochrome c indicated mitochondrial outer membrane
permeabilization (MOMP), and subsequently leading to apoptosis induc-
tion judged by the increased level of cleaved caspase 3. Furthermore, the
reduced cell viability, the release of CatB and CatD, the level of cytosolic
cytochrome c and cleaved caspase3 were attenuated by the pretreatment
of pepstatinA/E64 which are inhibitors of lysosomal protease suggesting
CQ induced LMP is responsible for CQ-induced apoptotic cell death in
human BC cells.
Conclusion: CQ exhibits cytotoxicity in human bladder cancer cells by
enhancing LMP that ampliﬁes apoptotic signaling and ultimately leading
to cell death.
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Purpose: Robotic partial nephrectomy is an increasingly performed,
minimally invasive alternative to open partial nephrectomy. We compared
early postoperative outcomes in 102 patients undergoing robotic and open
partial nephrectomy.
Materials and Methods: Data on 102 consecutive robotic or open partial
nephrectomies were collected retrospectively from 2008 to 2014 in our
centers. Demographic, intraoperative, postoperative and followup data
were compared between the 2 groups.
Results: Between the robotic (n¼ 59) and open (n¼ 43) partial nephrec-
tomy groups signiﬁcant differences were noted in ischemic time (31.86 vs
46.70minutes, p< 0.001), and preoperative glomerular ﬁltration rate (92.8
vs 78.2 ml/minute/1.73 m2, P¼ 0.004). Sex, surgical margin, blood loss,
mean hospitalization days, complication rate, postoperative blood trans-
fusion rate, recurrent rate andmortality rate were similar between the two
groups. Preoperative glomerular ﬁltration rate is the only risk factor of
postoperative glomerular ﬁltration rate declined at one year (p¼ 0.005).
Patients in the robotic group with preoperative GFR< 74.49 ml/minute/
1.73 m2 and open group preoperative GFR< 57.06 with ml/minute/1.73m2
were far more likely (p< 0.001) to have an estimated glomerular ﬁltration
rate less than 45 ml/minute/1.73 m2 after postoperative one year follow-
up.
Conclusion: Our results suggest that preoperative GFR was the most ac-
curate predictor of actual postoperative renal function at one year.
Although ischemia type and ischemia time were not associated with renal
function at postoperative one year, open partial nephrectomy is more
favorable than robotic partial nephrectomy in terms of patient with worse
preoperative renal function.
